Opiant Pharmaceuticals (OPNT) – Business Wire
-
Deepwatch Names Mel Wesley as Chief Financial Officer
-
Velan Launches Consent Solicitation to Reconstitute the Progenics Board With Its Five Highly-Qualified, Independent Director Nominees
Back to OPNT Stock Lookup
